Orchestra BioMed Inc. (OBIO)
NASDAQ: OBIO
· Real-Time Price · USD
3.05
-0.21 (-6.44%)
At close: Jun 05, 2025, 3:59 PM
3.18
4.26%
After-hours: Jun 05, 2025, 05:39 PM EDT
-6.44% (1D)
Bid | 3 |
Market Cap | 116.85M |
Revenue (ttm) | 2.89M |
Net Income (ttm) | -66.32M |
EPS (ttm) | -1.77 |
PE Ratio (ttm) | -1.72 |
Forward PE | -1.84 |
Analyst | Buy |
Ask | 3.45 |
Volume | 224,240 |
Avg. Volume (20D) | 382,853 |
Open | 3.24 |
Previous Close | 3.26 |
Day's Range | 3.05 - 3.27 |
52-Week Range | 2.37 - 8.87 |
Beta | 0.63 |
About OBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+10.94%
Orchestra BioMed shares are trading higher after t...
Unlock content with
Pro Subscription
1 month ago
+0.7%
Orchestra BioMed shares are trading higher after the company announced it secured FDA Breakthrough Device Designation for AVIM therapy.